Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.395 USD | -3.12% | -0.71% | -87.12% |
Apr. 17 | Truist Adjusts Marinus Pharmaceuticals' PT to $10 From $25, Keeps Buy Rating | MT |
Apr. 16 | Baird Downgrades Marinus Pharmaceuticals to Neutral, Price Target at $2 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-87.12% | 79.09M | |
+24.37% | 562B | |
-6.32% | 358B | |
+18.98% | 322B | |
+7.41% | 297B | |
+12.94% | 219B | |
+5.94% | 199B | |
-10.43% | 196B | |
-10.65% | 149B | |
-6.64% | 146B |
- Stock Market
- Equities
- MRNS Stock
- News Marinus Pharmaceuticals, Inc.
- Transcript : Marinus Pharmaceuticals, Inc., Q2 2021 Earnings Call, Aug 10, 2021